In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus

Hepatitis delta virus (HDV) can dramatically worsen liver disease in patients coinfected with hepatitis B virus (HBV). No effective medical therapy exists for HDV. The HDV envelope requires HBV surface antigen proteins provided by HBV. Once inside a cell, however, HDV can replicate its genome in the...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Invest
Autori principali:	Bordier, Bruno B., Ohkanda, Junko, Liu, Ping, Lee, So-Young, Salazar, F.H., Marion, Patricia L., Ohashi, Kazuo, Meuse, Leonard, Kay, Mark A., Casey, John L., Sebti, Saïd M., Hamilton, Andrew D., Glenn, Jeffrey S.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Clinical Investigation 2003
Soggetti:	Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166292/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12897208/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI17704
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!